PRMT5 inhibition in MCL
Ontology highlight
ABSTRACT: To identify the mechanistic underpinning of the anti-tumor activity of PRMT5 inhibition in MCL, we explored transcriptomic profiles of PDX-AA cells treated in vivo for 2 weeks with PRT-382, ibrutinib, or vehicle control (n=3/group).
ORGANISM(S): Homo sapiens
PROVIDER: GSE220936 | GEO | 2023/09/27
REPOSITORIES: GEO
ACCESS DATA